Hepatic Impairment Study With MDV3100 in Subjects With Mild and Moderate Hepatic Impairment Compared to a Healthy Control Group

Clinical trial NCT01901133 · COMPLETED

Trial details

NCT number: NCT01901133
Sponsor: Astellas Pharma Europe B.V.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacokinetics of MDV3100 Healthy Subjects Kidney Diseases

Start date: 2011-10-01
Primary completion: 2012-01-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.